| Christopher Joseph Palombo, MD | |
|
2580 Constitution Blvd, Beaver Falls, PA 15010-1294 | |
| (724) 843-0737 | |
| (724) 770-7922 |
| Full Name | Christopher Joseph Palombo |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 36 Years |
| Location | 2580 Constitution Blvd, Beaver Falls, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639179039 | NPI | - | NPPES |
| 01401318 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD043222L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Heritage Valley Beaver | Beaver, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tri State Obstetrics And Gynecology | 5597659334 | 8 |
News Archive
Genzyme Corporation announced today that the first patient has been treated in a new phase 2 clinical trial examining the safety and effectiveness of locally delivered gene transfer for patients with peripheral arterial disease.
Cancer of the pancreas-a glandular organ that lies behind the stomach and secretes vital enzymes and hormones-seldom is detected in early stages, making treatment difficult and survival statistics particularly grim. However, new research from Fox Chase Cancer Center finds that patients with pancreatic adenocarcinoma whose tumors respond most to preoperative chemotherapy and radiation survive four times as long, on average, as those whose tumors respond least.
Scientists in the Netherlands recently conducted an open-level, randomized-controlled trial to evaluate the safety and immunogenicity of fractional intradermal doses of the mRNA-based COVID-19 vaccine mRNA-1273 (Moderna). The trial findings reveal that the fractional dose regimen of the Moderna vaccine is well tolerated and safe and is capable of inducing robust antibody responses in vaccine recipients. The study is currently available on the medRxiv* preprint server.
Researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have found a way to defeat one of the most tantalizing yet elusive target proteins in cancer cells - employing a strategy that turns the protein's own molecular machinations against it.
Detroit-area resident Melvin Young pleaded guilty today to engaging in a fraudulent medical testing scheme, announced the Departments of Justice and Health and Human Services (HHS).
› Verified 5 days ago
| Entity Name | Tri State Obstetrics & Gynecology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568419281 PECOS PAC ID: 5597659334 Enrollment ID: O20040211001136 |
News Archive
Genzyme Corporation announced today that the first patient has been treated in a new phase 2 clinical trial examining the safety and effectiveness of locally delivered gene transfer for patients with peripheral arterial disease.
Cancer of the pancreas-a glandular organ that lies behind the stomach and secretes vital enzymes and hormones-seldom is detected in early stages, making treatment difficult and survival statistics particularly grim. However, new research from Fox Chase Cancer Center finds that patients with pancreatic adenocarcinoma whose tumors respond most to preoperative chemotherapy and radiation survive four times as long, on average, as those whose tumors respond least.
Scientists in the Netherlands recently conducted an open-level, randomized-controlled trial to evaluate the safety and immunogenicity of fractional intradermal doses of the mRNA-based COVID-19 vaccine mRNA-1273 (Moderna). The trial findings reveal that the fractional dose regimen of the Moderna vaccine is well tolerated and safe and is capable of inducing robust antibody responses in vaccine recipients. The study is currently available on the medRxiv* preprint server.
Researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have found a way to defeat one of the most tantalizing yet elusive target proteins in cancer cells - employing a strategy that turns the protein's own molecular machinations against it.
Detroit-area resident Melvin Young pleaded guilty today to engaging in a fraudulent medical testing scheme, announced the Departments of Justice and Health and Human Services (HHS).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Joseph Palombo, MD 2580 Constitution Blvd, Beaver Falls, PA 15010-1294 Ph: (724) 843-0737 | Christopher Joseph Palombo, MD 2580 Constitution Blvd, Beaver Falls, PA 15010-1294 Ph: (724) 843-0737 |
News Archive
Genzyme Corporation announced today that the first patient has been treated in a new phase 2 clinical trial examining the safety and effectiveness of locally delivered gene transfer for patients with peripheral arterial disease.
Cancer of the pancreas-a glandular organ that lies behind the stomach and secretes vital enzymes and hormones-seldom is detected in early stages, making treatment difficult and survival statistics particularly grim. However, new research from Fox Chase Cancer Center finds that patients with pancreatic adenocarcinoma whose tumors respond most to preoperative chemotherapy and radiation survive four times as long, on average, as those whose tumors respond least.
Scientists in the Netherlands recently conducted an open-level, randomized-controlled trial to evaluate the safety and immunogenicity of fractional intradermal doses of the mRNA-based COVID-19 vaccine mRNA-1273 (Moderna). The trial findings reveal that the fractional dose regimen of the Moderna vaccine is well tolerated and safe and is capable of inducing robust antibody responses in vaccine recipients. The study is currently available on the medRxiv* preprint server.
Researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have found a way to defeat one of the most tantalizing yet elusive target proteins in cancer cells - employing a strategy that turns the protein's own molecular machinations against it.
Detroit-area resident Melvin Young pleaded guilty today to engaging in a fraudulent medical testing scheme, announced the Departments of Justice and Health and Human Services (HHS).
› Verified 5 days ago
Paula S. Youngdahl, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2580 Constitution Blvd, Beaver Falls, PA 15010 Phone: 724-843-0737 Fax: 724-843-0833 | |
Mrs. Patricia Nicholette Vigder, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2620 Constitution Blvd, Upper Level, Beaver Falls, PA 15010 Phone: 724-843-0737 Fax: 724-770-7922 | |
Kevin Clayton Dumpe, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1302 7th Ave, Beaver Falls, PA 15010 Phone: 724-843-4010 Fax: 724-843-8727 | |
Edwin W. Cheek, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2674 Darlington Rd, Beaver Falls, PA 15010 Phone: 724-846-0430 Fax: 724-746-0705 | |
Sophia Tsiris Kunkle, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1302 7th Ave, Beaver Falls, PA 15010 Phone: 724-843-4010 Fax: 724-846-0588 | |
William P. Rumbaugh, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2620 Constitution Blvd, Upper Level, Beaver Falls, PA 15010 Phone: 724-843-0737 |